Transaction in Own Shares

Barclays PLC

03 September 2024

 

3 September 2024

Barclays PLC

Transaction in own shares

Barclays PLC (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of 25 pence each on the London Stock Exchange from Citigroup Global Markets Limited as part of its buy-back announced on 5 August 2024:

Date of purchase:	2 September 2024
Number of ordinary shares purchased:	3,761,842
Highest price paid per share:	229.7500p
Lowest price paid per share:	226.6500p
Volume weighted average price paid per share:	228.2755p

The Company intends to cancel all of the purchased ordinary shares.

Following the cancellation of the repurchased shares, the Company's issued share capital will consist of 14,640,131,716 ordinary shares with voting rights.¹

There are no ordinary shares held in Treasury.

The above figure (14,640,131,716) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a full breakdown of the individual purchases of ordinary shares made by Citigroup Global Markets Limited on behalf of the Company can be found at:

http://www.rns-pdf.londonstockexchange.com/rns/6138C_1-2024-9-2.pdf

Since the commencement of the share buy-back programme announced on 5 August 2024, the Company has purchased 81,508,564 ordinary shares on the London Stock Exchange in aggregate at a volume weighted average price of 221.6384p per ordinary share.

Note:

1.     Please note a correction to the Company's issued share capital disclosed in each of the RNS announcements issued from 10 August 2024 to 2 September 2024 (inclusive) related to transactions in own shares. The Company's issued share capital disclosed in each of the RNS announcements related to transactions in own shares released on those dates was understated by 270 ordinary shares with voting rights. This RNS reflects the correct issued share capital.

- ENDS -

For further information, please contact:

Investor Relations                                                           Media Relations

Marina Shchukina [phone]                   Tom Hoskin [phone]

 

END